financetom
Business
financetom
/
Business
/
Ansell to buy Kimberley-Clark's personal protective equipment unit for $640 mln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ansell to buy Kimberley-Clark's personal protective equipment unit for $640 mln
Apr 7, 2024 5:21 PM

April 8 (Reuters) - Australian glove maker Ansell Ltd ( ANSLF )

said on Monday it will buy the personal protective

equipment unit of U.S.-based Kimberly-Clark ( KMB ) for $640

million, and expects to complete the acquisition in the first

quarter of financial year 2025.

Acquisition will be funded by a A$400 million fully

underwritten institutional placement and a new $377 million

bridge facility, Ansell ( ANSLF ) said in a statement.

The personal protective equipment division of Kleenex tissue

maker Kimberly-Clark ( KMB ) is engaged in creating and retailing

specialized safety goods such as gloves, protective clothing,

and safety eye-wear.

"With this acquisition we are enhancing our sales of

specialist products designed for clean room applications, while

also widening our portfolio of products sold into Scientific

verticals," Ansell Managing Director and CEO Neil Salmon said.

Under the deal, Ansell ( ANSLF ) and Kimberley-Clark (K-C) will

enter a transitional services arrangement whereby K-C will offer

a range of business support services to Ansell's ( ANSLF ) customers,

suppliers, and employees within a maximum 12-month period.

Ansell ( ANSLF ) said it expects around $10 million per annum

run-rate net cost synergies to be achieved by the third full

year of ownership.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zimmer Biomet's Q3 Adjusted Earnings, Net Sales Rise; Fiscal 2024 Outlook Updated
Zimmer Biomet's Q3 Adjusted Earnings, Net Sales Rise; Fiscal 2024 Outlook Updated
Nov 3, 2024
07:13 AM EDT, 10/30/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) reported Q3 adjusted earnings Wednesday of $1.74 per diluted share, up from $1.65 a year earlier. Analysts polled by Capital IQ expected $1.74. Net sales for the quarter ended Sept. 30 were $1.82 billion, up from $1.75 billion a year earlier. Analysts surveyed by Capital IQ expected...
United Microelectronics Q3 Earnings Fall, Revenue Rises
United Microelectronics Q3 Earnings Fall, Revenue Rises
Nov 3, 2024
07:11 AM EDT, 10/30/2024 (MT Newswires) -- United Microelectronics ( UMC ) reported Q3 earnings Wednesday of 1.16 New Taiwan dollars ($0.04) per diluted share, down from NT$1.29 a year earlier. Analysts polled by Capital IQ expected NT$1.13. Revenue for the quarter ended Sept. 30 was NT$60.49 billion compared with NT$57.07 billion a year earlier. Analysts surveyed by Capital IQ...
Otis cuts FY sales forecast as quarterly results miss on China weakness
Otis cuts FY sales forecast as quarterly results miss on China weakness
Nov 3, 2024
Oct 30(Reuters) - Otis cut its annual sales forecast and marginally missed third-quarter estimates on Wednesday, as the elevator maker navigates a challenging Chinese property market. Weak construction activity in North America and Europe and pressure on China's real estate activity continued to impact the elevator maker's new equipment sales during the quarter. Otis now expects its annual sales to...
United Therapeutics' Q3 Earnings, Revenue Rise
United Therapeutics' Q3 Earnings, Revenue Rise
Nov 3, 2024
07:13 AM EDT, 10/30/2024 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q3 earnings Wednesday of $6.39 per diluted share, up from $5.38 a year earlier. Analysts polled by Capital IQ expected $6.42. Revenue for the quarter ended Sept. 30 was $748.9 million, compared with $609.4 million a year earlier. Analysts polled by Capital IQ expected $722.8 million. Price:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved